Heart Failure

Pharmacists working along with other health care providers can help improve outcomes for heart failure patients, according to the results of a pair of studies presented at the Heart Failure Society of America meeting.

Although obesity is a known risk factor for cardiac disease, several recent studies have found that obesity does not seem to be an indicator of premature death.

Heart failure patients younger than 60 years of age who took warfarin experienced significantly fewer adverse events than those who took aspirin, a new study finds.

Middle-aged men who took statins for 5 years had a substantially lower hospitalization rate and reduced health care costs over a 15-year period.

The primary care physician for a 67-year-old female patient with hypertension, dyslipidemia, and chronic non-ischemic systolic heart failure wants to know whether to initiate an antithrombotic agent.

A new study finds that increased access to MTM services for Medicare Part D beneficiaries with chronic conditions could increase medication adherence, reduce costs, and improve outcomes.

A study finds that use of sulfonylureas in the period leading up to an acute coronary syndrome is not associated with increased risk of death or heart failure.

This triple therapy can increase the risk of acute renal failure.

More than half a million Americans die from heart disease each year, but increased attention to its risk factors can help reduce this number.

As part of an interdisciplinary team at Pennsylvania Hospital, clinical pharmacists helped improve performance on 9 medication-related core measures.

This video, from the Cleveland Clinic, discusses a syndrome in which generally healthy people who drink more than usual at the holidays can experience heart problems.

Although pharmacist interventions didn't reduce hospitalizations or death rates, they did result in more patients getting the recommended medications.